| Ajanta Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532331 |
NSE Symbol : AJANTPHARM |
P/E(TTM) : 34.69 |
|
ISIN Demat : INE031B01049 |
Div & Yield% : 1.06 |
EPS(TTM) : 76.07 |
|
Book Value(₹) : 330.39 |
Market Cap(₹Cr) : 32,967.39 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4,322.04 | 3,971.12 | 3,411.27 | 3,140.64 | 2,718.59 |
| Other Income | 119.87 | 116.48 | 132.75 | 139.73 | 103.57 |
| Stock Adjustments | 18.58 | 22.17 | 21.99 | 56.60 | 74.60 |
| Total Income | 4,460.49 | 4,109.77 | 3,566.01 | 3,336.97 | 2,896.76 |
| EXPENDITURE : | |||||
| Raw Materials | 1,030.60 | 1,101.59 | 1,027.40 | 889.16 | 804.68 |
| Power and Fuel Cost | 70.22 | 66.44 | 65.53 | 54.09 | 43.42 |
| Other Manufacturing Expenses | 198.94 | 168.11 | 185.50 | 169.95 | 119.25 |
| Selling and Administration Expenses | 695.46 | 587.02 | 602.95 | 512.46 | 324.31 |
| Miscellaneous Expenses | 129.78 | 116.54 | 132.19 | 94.82 | 86.51 |
| Employee Benefit Expenses | 1,010.90 | 834.16 | 720.41 | 585.87 | 498.11 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,324.59 | 1,235.91 | 832.03 | 1,030.62 | 1,020.48 |
| Interest | 4.60 | 6.80 | 5.23 | 9.12 | 6.90 |
| Gross Profit | 1,319.99 | 1,229.11 | 826.80 | 1,021.50 | 1,013.58 |
| Depreciation | 139.93 | 132.16 | 126.95 | 120.96 | 111.49 |
| Profit Before Tax | 1,180.06 | 1,096.95 | 699.85 | 900.54 | 902.09 |
| Current Tax | 258.03 | 280.56 | 141.08 | 171.17 | 216.68 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 5.14 | 9.15 | 0.05 | 9.51 | 9.77 |
| Reported Net Profit | 916.89 | 807.24 | 558.72 | 719.86 | 675.64 |
| Extraordinary Items | 10.88 | 11.11 | 12.87 | -0.62 | 2.91 |
| Adjusted Net Profit | 906.01 | 796.13 | 545.85 | 720.48 | 672.73 |
| Adjustment below Net Profit | -213.11 | -0.92 | -74.72 | -68.50 | -32.42 |
| Profit/Loss Balance carried down | 3,253.44 | 3,089.29 | 2,694.98 | 2,125.83 | 1,565.51 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 349.75 | 642.17 | 89.69 | 82.21 | 82.90 |
| P & L Balance carried down | 3,607.47 | 3,253.44 | 3,089.29 | 2,694.98 | 2,125.83 |
| Dividend | 349.75 | 642.17 | 89.69 | 82.21 | 82.90 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,400.00 | 2,550.00 | 350.00 | 475.00 | 475.00 |
| Dividend Per Share(Rs) | 28.00 | 51.00 | 7.00 | 9.50 | 9.50 |
| Earnings Per Share-Unit Curr | 73.15 | 63.89 | 44.22 | 83.85 | 77.70 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 289.21 | 270.17 | 256.94 | 369.15 | 331.80 |
| Book Value(Adj)-Unit Curr | 289.21 | 270.17 | 256.94 | 246.10 | 221.20 |